BARBARA WENDLAND: Open Payments
NPI 1508943358 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 19 payments from 13 companies in 2025. Trend: 2023 $111 · 2024 $165 · 2025 $632
Food & beverage: $545Education: $87
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Ipsen Biopharmaceuticals, Inc | 2 | $69 |
| Daiichi Sankyo Inc. | 2 | $50 |
| BeOne Medicines USA, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Celgene Corporation | 1 | $28 |
| Geron Corporation | 1 | $28 |
| TAIHO ONCOLOGY, INC. | 1 | $26 |
| Eisai Inc. | 1 | $25 |
Products named: OPDIVO, ENHERTU, Onivyde, Vanflyta, BRUKINSA, VONVENDI, RYTELO, LONSURF.
Industry payments across CA — which companies pay providers there.
